Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NASDAQ:BRTXNYSE:CONYSE:CORBFNASDAQ:VMD On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeBRTXBioRestorative Therapies$1.73-4.2%$1.93$1.03▼$2.55$12.95M68.9666,662 shs46,264 shsCOGlobal Cord Blood$1.15+9.5%$0.95$2.03▼$5.50$363.15M0.16216,519 shs6,375 shsCORBFGlobal Cord Blood$1.15+9.5%$0.95$0.25▼$2.00$139.78M-0.64200,241 shs6,375 shsVMDViemed Healthcare$6.88-2.7%$7.70$6.21▼$9.81$279.42M1.64136,420 shs165,310 shs7 Energy Stocks to Buy and Hold ForeverWith the proliferation of data centers and electric vehicles, the electric grid will only get more strained. Download this report to learn how energy stocks can play a role in your portfolio as the global demand for energy continues to grow.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceBRTXBioRestorative Therapies0.00%-4.70%+14.24%+15.00%+31.68%COGlobal Cord Blood+9.52%+43.75%0.00%+13.86%-14.81%CORBFGlobal Cord Blood0.00%+43.75%+12.75%+13.86%-14.81%VMDViemed Healthcare0.00%-5.36%-7.77%-15.27%-23.13%Remove AdsCompare MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationBRTXBioRestorative Therapies2.7819 of 5 stars3.54.00.00.00.03.31.3COGlobal Cord BloodN/AN/AN/AN/AN/AN/AN/AN/ACORBFGlobal Cord BloodN/AN/AN/AN/AN/AN/AN/AN/AVMDViemed Healthcare0.8903 of 5 stars0.03.00.00.03.12.50.0Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceBRTXBioRestorative Therapies 3.00Buy$18.00943.48% UpsideCOGlobal Cord Blood 0.00N/AN/AN/ACORBFGlobal Cord Blood 0.00N/AN/AN/AVMDViemed Healthcare 4.00Strong BuyN/AN/ACurrent Analyst Ratings BreakdownCompare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookBRTXBioRestorative Therapies$377K34.34N/AN/A$2.45 per share0.70COGlobal Cord Blood$1.24B0.11$0.27 per share4.19$6.34 per share0.18CORBFGlobal Cord Blood$196.12M0.71$0.82 per share1.40N/A∞VMDViemed Healthcare$224.26M1.21$0.72 per share9.56$2.96 per share2.32Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateBRTXBioRestorative Therapies-$14.41M-$1.16N/AN/AN/A-2,697.08%-98.49%-75.23%5/12/2025 (Estimated)COGlobal Cord Blood$79.04M$0.641.80∞N/AN/AN/AN/AN/ACORBFGlobal Cord Blood$79.04MN/A0.00∞N/AN/AN/AN/AN/AVMDViemed Healthcare$10.24M$0.2825.48∞N/A4.87%8.72%6.48%5/5/2025 (Estimated)Latest CO, VMD, CORBF, and BRTX EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails3/27/2025Q4 2024BRTXBioRestorative Therapies-$0.27-$0.20+$0.07-$0.20$0.48 million$0.50 millionCompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthBRTXBioRestorative TherapiesN/AN/AN/AN/AN/ACOGlobal Cord Blood$0.086.96%N/A12.50%N/ACORBFGlobal Cord BloodN/AN/AN/AN/AN/AVMDViemed HealthcareN/AN/AN/AN/AN/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioBRTXBioRestorative TherapiesN/A2.952.95COGlobal Cord BloodN/AN/AN/ACORBFGlobal Cord BloodN/AN/AN/AVMDViemed Healthcare0.031.311.19Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipBRTXBioRestorative Therapies69.38%COGlobal Cord BloodN/ACORBFGlobal Cord BloodN/AVMDViemed Healthcare74.24%Insider OwnershipCompanyInsider OwnershipBRTXBioRestorative Therapies25.50%COGlobal Cord Blood0.50%CORBFGlobal Cord Blood0.50%VMDViemed Healthcare20.00%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableBRTXBioRestorative Therapies77.51 million5.16 millionNot OptionableCOGlobal Cord Blood1,202121.55 millionN/ANo DataCORBFGlobal Cord Blood1,200121.55 millionN/ANot OptionableVMDViemed Healthcare63039.52 million31.15 millionNot OptionableCO, VMD, CORBF, and BRTX HeadlinesRecent News About These CompaniesCove Street Capital LLC Sells 188,906 Shares of Viemed Healthcare, Inc. (NASDAQ:VMD)March 31, 2025 | marketbeat.comSegall Bryant & Hamill LLC Acquires New Holdings in Viemed Healthcare, Inc. (NASDAQ:VMD)March 30, 2025 | marketbeat.comViemed Healthcare, Inc. (VMD): A Bull Case TheoryMarch 28, 2025 | insidermonkey.comBoston Partners Has $351,000 Stake in Viemed Healthcare, Inc. (NASDAQ:VMD)March 24, 2025 | marketbeat.comGlobeflex Capital L P Makes New Investment in Viemed Healthcare, Inc. (NASDAQ:VMD)March 17, 2025 | marketbeat.comFirst Eagle Investment Management LLC Acquires 217,923 Shares of Viemed Healthcare, Inc. (NASDAQ:VMD)March 17, 2025 | marketbeat.comViemed stays ‘nimble’March 15, 2025 | hmenews.comIn Lafayette, health care jobs continue to rise. VieMed is a key reason why.March 13, 2025 | theadvocate.comViemed Healthcare, Inc. (VMD) Q4 2024 Earnings Call TranscriptMarch 11, 2025 | seekingalpha.comViemed Healthcare (NASDAQ:VMD) Releases Quarterly Earnings Results, Beats Estimates By $0.02 EPSMarch 11, 2025 | marketbeat.comViemed Healthcare Announces Record 2024 Financial ResultsMarch 10, 2025 | globenewswire.comTrading (VMD) With Integrated Risk ControlsDecember 17, 2024 | news.stocktradersdaily.comViemed Healthcare, Inc. (NASDAQ:VMD) Director Nitin Kaushal Sells 5,995 SharesNovember 27, 2024 | insidertrades.comThis Lafayette health care company reported 17% increase in net revenue last quarterNovember 21, 2024 | theadvocate.comViemed healthcare director Kaushal Nitin sells shares worth $571,200November 15, 2024 | investing.comViemed healthcare director sells shares worth $571,200November 15, 2024 | investing.comInsider Selling: Viemed Healthcare, Inc. (NASDAQ:VMD) Director Sells 30,000 Shares of StockNovember 14, 2024 | insidertrades.comViemed Healthcare, Inc. (VMD) Q3 2024 Earnings Call TranscriptNovember 9, 2024 | seekingalpha.comViemed Healthcare Inc (VMD) Q3 2024 Earnings Call Highlights: Record Revenue and Strategic ...November 8, 2024 | finance.yahoo.comViemed Healthcare, Inc.: Viemed Healthcare Announces Third Quarter 2024 Financial ResultsNovember 8, 2024 | finanznachrichten.deViemed Healthcare (VMD) Gets a Buy from Lake StreetNovember 8, 2024 | markets.businessinsider.comNew MarketBeat Followers Over TimeMedia Sentiment Over TimeTop HeadlinesView All HeadlinesBYD Unveils Ultra-Fast Charging—Will It Supercharge BYDDY Stock?By Jeffrey Neal Johnson | March 21, 2025View BYD Unveils Ultra-Fast Charging—Will It Supercharge BYDDY Stock?NVIDIA’s Soaring Energy Needs Make These 3 Nuclear Stocks a BuyBy Thomas Hughes | March 12, 2025View NVIDIA’s Soaring Energy Needs Make These 3 Nuclear Stocks a Buy3 Defense Stocks Set to Benefit From Increased Military SpendingBy Chris Markoch | March 20, 2025View 3 Defense Stocks Set to Benefit From Increased Military SpendingNVIDIA Stock Remains Stunningly Undervalued—Here’s WhyBy Thomas Hughes | March 11, 2025View NVIDIA Stock Remains Stunningly Undervalued—Here’s Why3 Stocks Near 52-Week Lows With Strong Rebound PotentialBy Gabriel Osorio-Mazilli | March 31, 2025View 3 Stocks Near 52-Week Lows With Strong Rebound PotentialCO, VMD, CORBF, and BRTX Company DescriptionsBioRestorative Therapies NASDAQ:BRTX$1.72 -0.08 (-4.17%) Closing price 04/4/2025 03:56 PM EasternExtended Trading$1.73 +0.00 (+0.06%) As of 04/4/2025 05:51 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.BioRestorative Therapies, Inc., a life sciences company, focuses on the development of regenerative medicine products and therapies using cell and tissue protocols primarily involving adult stem cells. The company's two core developmental programs relate to the treatment of disc/spine disease and metabolic disorders. Its disc/spine program (brtxDisc) includes a lead cell therapy candidate, BRTX-100, a product candidate formulated from autologous cultured mesenchymal stem cells collected from the patient's bone marrow, which has completed Phase 1 clinical trials for use in the non-surgical treatment of painful lumbosacral disc disorders. The company is also developing Metabolic Program (ThermoStem), a cell-based therapy candidate that is in preclinical stage to target obesity and metabolic disorders using brown adipose derived stem cells to generate brown adipose tissue. In addition, it provides investigational curved needle device designed to deliver cells and/or other therapeutic products or material to the spine and discs. BioRestorative Therapies, Inc. has a research and development agreement with Rohto Pharmaceutical Co., Ltd.; a research agreement with Pfizer, Inc.; and a research collaboration agreement with the University of Pennsylvania. The company was formerly known as Stem Cell Assurance, Inc. and changed its name to BioRestorative Therapies, Inc. in August 2011. The company was incorporated in 1997 and is based in Melville, New York.Global Cord Blood NYSE:CO$1.15 +0.10 (+9.52%) As of 04/4/2025Global Cord Blood operates as a holding company, which engages in the provision of cord blood banking services. It provides cord blood processing and storage service. The company also offers cord blood collection, laboratory testing, hematopoietic stem cell processing and stem cell storage services. The firm preserves cord blood units donated by the public and provides matching services on such donated units and deliver matching units to patients in need of transplants. Global Cord Blood was founded on January 17, 2008 and is headquartered in Hong Kong.Global Cord Blood NYSE:CORBF$1.15 +0.10 (+9.52%) As of 04/4/2025 10:15 AM EasternGlobal Cord Blood Corporation, together with its subsidiaries, provides umbilical cord blood storage and ancillary services in the People's Republic of China. The company offers cord blood testing, processing, and storage services under the direction of subscribers; and tests, processes, and stores donated cord blood, as well as provides matching services. As of March 31, 2022, it operated three cord blood banks, including one in the Beijing municipality; one in the Guangdong province; and one in the Zhejiang province. The company was formerly known as China Cord Blood Corporation and changed its name to Global Cord Blood Corporation in March 2018. Global Cord Blood Corporation is based in Central, Hong Kong. Global Cord Blood Corporation operates as a subsidiary of Blue Ocean Structure Investment Company Ltd.Viemed Healthcare NASDAQ:VMD$6.88 -0.19 (-2.69%) Closing price 04/4/2025 04:00 PM EasternExtended Trading$6.90 +0.01 (+0.22%) As of 04/4/2025 04:05 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Viemed Healthcare, Inc., together with its subsidiaries, provides home medical equipment (HME) and post-acute respiratory healthcare services to patients in the United States. It provides respiratory disease management solutions, including treatment of chronic obstructive pulmonary disease (COPD), which include non-invasive ventilation, percussion vests, and other therapies; and invasive and non-invasive ventilation and related equipment and supplies to patients suffering from COPD. The company leases non-invasive and invasive ventilators, positive airway pressure machines (PAP), durable medical equipment, percussion vests, oxygen concentrators, and other medical equipment; and sells and rents HME devices. In addition, it provides neuromuscular care and oxygen therapy services; and sleep apnea management provides sleep solutions and/or equipment, such as PAP, automatic continuous positive airway pressure, and bi-level positive airway pressure machines. Further, the company offers in home sleep apnea testing services, as well as healthcare staffing and recruitment services. Viemed Healthcare, Inc. was founded in 2006 and is headquartered in Lafayette, Louisiana. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30EcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas MarketBeat Week in Review – 03/31 - 04/04 Newsmax’s IPO Whiplash: Meme Stock Hype or Growth Potential? Conagra Stock Could Thrive as Tariffs Hit Other Sectors Archer Aviation’s Africa Deal Could Boost ACHR Stock The Ecosystem Edge: Joby's Competitive Advantage Advance Auto Parts Stock: A Classic Rebound Play in the Making Intel’s Big Bet on 18A: Will Lip-Bu Tan’s Vision Pay Off? Lamb Weston Stock Rises, Earnings Provide Calm Amidst Chaos Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
